Devin Abrahami MSc, ADA 2019 – Fracture Risk in Patients Using SGLT2 Inhibitors
We are joined by Devin Abrahami to discuss her poster session at the ADA 2019 annual meeting: Fracture risk in patients using sodium-glucose cotransporter 2 inhibitors: a real-world study.
Filmed at the American Diabetes Association (ADA) annual meeting 2019, San Francisco, USA.
1. Why are patients with type 2 diabetes at enhanced risk of fractures? (0:05)
2. What are the effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism? (1:28)
3. Could you tell us a little about the design and findings of your study? (2:31)
4. Which patient groups were at greatest risk of fracture? (3:54)
5. What were the limitations of your study and what future research is needed? (4:35)
Devin Abrahami has no conflicts of interest to declare in relation to this video.
touchENDO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Share this Video
Related Videos In Diabetes
Chantal Mathieu: Research highlights from 2022 in diabetes
2022 saw the FDA approval of teplizumab to delay the onset of type 1 diabetes. In addition, there has also been evidence to suggest the effectivness of SGLT2 inhibitors in type 1 diabetes. We were delighted to speak with our editorial board member Prof. Chantal Mathieu (University Hospital Gasthuisberg Leuven, Leuven, Belgium) around this year’s research […]
José García-Tirado, DTM 2022: RocketAP in Practice: Results from Pilot and Feasibility Trials
In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) gives an overview of RocketAP and discusses how the RocketAP compares to the USS-Virginia system and also what the next steps in the clinical development of the Rocket AP will be. The abstract entitled: ‘RocketAP in Practice: Results from Pilot and Feasibility […]
José García-Tirado, DTM 2022: Challenges in the development of artificial pancreas systems
An artificial pancreas is a system made of three parts that work together to mimic how a healthy pancreas controls blood glucose in the body. In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) discusses the major challenges in the development of artificial pancreas systems. The abstract entitled: ‘RocketAP in Practice: Results from Pilot […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!